| Date | Form | Description | Docs | XBRL | Pages |
| 10/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/29/17 | 8-K | Current report filing |
|
34 | |
| 09/29/17 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
52 | |
| 09/27/17 | 8-K | Current report filing |
|
3 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/13/17 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
15 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...